The Chemours Company
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0HWG.L | KRO | VHI | S5M.F | TROX | TATACHEM.NS | |
|---|---|---|---|---|---|---|
| Market cap | — | 860.93M | 393.66M | 525.58M | 529.41M | 151.35B |
| P/E (TTM) | 2.9 | — | — | 25.0 | — | — |
| Forward P/E | — | 12.2 | 4.3 | — | -7.3 | 20.0 |
| Price/book | -39.8 | 1.1 | 0.4 | 1.8 | 0.5 | 0.7 |
| Dividend yield | 2.78% | 2.67% | 2.29% | 0.61% | 6.14% | 1.82% |
| 1-year change | −6.29% | +54.87% | −3.12% | −12.41% | −12.60% | −33.03% |
| Today | +2.78% | −0.93% | −0.50% | 0.00% | +1.69% | −1.95% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All 0HWG.L news ›Solstice and Chemours Enforce HFO Refrigerant Patents at Chillventa 2026
Court orders targeted exhibitors over manufacturing processes and refrigerant blends, with Solstice noting that affected firms may appeal. According to Solstice, affected exhibitors may appeal the preliminary injunctions at any time. The…
INVESTOR ALERT: The Chemours Company (CC) Investors: December 7, 2026, Deadline in Securities Fraud Class Action Lawsuit
Did you buy CC securities between February 20, 2026 and August 4, 2026? Affected CC Investor Summary You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected]. There is no cost or obligation…
Shareholders who lost money in shares of The Chemours Company (NYSE: CC) should contact Wolf Haldenstein Immediately
Oct 20, 2026, 08:51 ET Lead Plaintiff Deadline December 7, 2026 Investors who purchased Chemours shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for…
Investor Alert: Chemours (CC) has been Sued for Securities Fraud Over Alleged Misstatements made to Investors
Oct 20, 2026, 05:36 ET Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products. NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Leading…
Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm
October 20, 2026 11:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC Bronstein, Gewirtz & Grossman, LLC NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm,…
What Should The Chemours Company Investors Know After 18.63% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
Oct 19, 2026, 21:05 ET Lawsuit alleges The Chemours Company made misleading statements to investors from February 20, 2026 to August 4, 2026; lead plaintiff motions are due December 7, 2026 If you lost money on The Chemours Company…
Chemours and Local Officials Take Action to Protect Refrigerant Intellectual Property at Chillventa
/PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company, today announces that it has taken action to protect its intellectual... Action reflects Chemours' commitment to innovation, intellectual property…
CC SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026
October 19, 2026 7:45 PM EDT | Source: Faruqi & Faruqi LLP Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If…
Kaplan Fox Reminds The Chemours Company (CC) Investors with Significant Losses to Seek a Leadership Role Before Deadline on December 7, 2026
October 19, 2026 9:05 AM EDT | Source: Kaplan Fox & Kilsheimer LLP New York, New York--(Newsfile Corp. - October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company…
Chemours: The Current Trajectory Is Not Reflective Of The Upside
Seeking Alpha - Chemours is rated 'BUY' with a $20 price target and $30 fair value, reflecting significant undervaluation and recovery potential. - CC's investment thesis centers on operating leverage, balance sheet repair, and recovery in…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
prnewswire.com14
-
globenewswire.com10
-
natlawreview.com6
-
newsfilecorp.com6
-
financialcontent.com4
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 73 articles, not a forecast.